Therefore, the present study performed time-dependent ROC analyses at three time points, 3, 4, and 5 years, to evaluate the predictive performance of ALT, AST, and the ALT/AST ratio for incident diabetes. This evidence concerns the gene GPT and diabetes mellitus.